摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(Indan-2-yloxy)-6-methoxy-2H-phthalazin-1-one | 228869-40-7

中文名称
——
中文别名
——
英文名称
5-(Indan-2-yloxy)-6-methoxy-2H-phthalazin-1-one
英文别名
5-(2,3-dihydro-1H-inden-2-yloxy)-6-methoxy-2H-phthalazin-1-one
5-(Indan-2-yloxy)-6-methoxy-2H-phthalazin-1-one化学式
CAS
228869-40-7
化学式
C18H16N2O3
mdl
——
分子量
308.337
InChiKey
DOFISRFKWUFWQF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    59.9
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    5-(Indan-2-yloxy)-6-methoxy-2H-phthalazin-1-one 在 sodium hydride 、 三氯氧磷 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 2.5h, 生成 1-[(3,5-dichloropyridin-4-yl)methyl]-5-(2,3-dihydro-1H-inden-2-yloxy)-6-methoxyphthalazine
    参考文献:
    名称:
    The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I
    摘要:
    This communication describes the synthesis and in vitro evaluation of a novel and potent series of phosphodiesterase type IV (PDE4) inhibitors. The compounds described represent conformationally constrained analogues of RP 73401, Piclamilast. Preliminary evidences of reduced side effects of 11 compared to standards are also reported. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(00)00449-2
  • 作为产物:
    描述:
    4-甲氧基-3-苯基甲氧基苯甲酰氯盐酸仲丁基锂 、 sodium carbonate 、 一水合肼溶剂黄146 、 potassium iodide 作用下, 以 四氢呋喃乙醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 39.08h, 生成 5-(Indan-2-yloxy)-6-methoxy-2H-phthalazin-1-one
    参考文献:
    名称:
    The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I
    摘要:
    This communication describes the synthesis and in vitro evaluation of a novel and potent series of phosphodiesterase type IV (PDE4) inhibitors. The compounds described represent conformationally constrained analogues of RP 73401, Piclamilast. Preliminary evidences of reduced side effects of 11 compared to standards are also reported. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(00)00449-2
点击查看最新优质反应信息

文献信息

  • Phthalazine derivatives as phosphodiesterase 4 inhibitors
    申请人:Zambon Group S.p.A.
    公开号:US06589951B1
    公开(公告)日:2003-07-08
    Compounds of formula (I) wherein B is alkylene, amino, CONH or a bond; Cy is optionally substituted phenyl or heteroaryl; R is H, phenyl or (C1-4)alkyl optionally substituted; R1 is (C1-6)alkyl or polyfluoro(C1-6)-alkyl; R2 is (C4-7)cycloalkyl optionally containing an oxygen atom and optionally substituted; and the N→O derivatives and pharmaceutically acceptable salt thereof are PDE 4 and TNF&agr; inhibitors.
    式(I)中的化合物,其中B是烷基,氨基,CONH或键;Cy是可选择地取代的苯基或杂环芳基;R是H,苯基或(C1-4)烷基可选择地取代;R1是(C1-6)烷基或多氟(C1-6)-烷基;R2是(C4-7)环烷基,可选地含有一个氧原子并可选择地取代;它们的N→O衍生物及其药用可接受的盐是PDE 4和TNF&agr;抑制剂。
  • Phthalazine derivatives as phosphodiesterase 4-inhibitors
    申请人:Zambon Group S.p.A
    公开号:US20040043999A1
    公开(公告)日:2004-03-04
    A process for preparing a compound of formula I: 1 wherein G is methylene, ethylene, CONH, amino or a bond; R is H, phenyl or a (C 1-4 )alkyl group optionally substituted by phenyl; Cy is phenyl or a 5- or 6-membered heterocycle of the group consisting of pyrrole, imidazole, pyrazole, pyrrolidine, pyrroline, imidazoline, imidazolidine, pyrazolidine, pyrazoline, pyridine, pyrazine, pyrimidine, pyridazine, piperazine, piperidine, and triazine, the Cy residue being optionally substituted by one or more substituent(s) selected from the group consisting of keto, nitro, carboxy, fluorine, chlorine, bromine, or iodine; R 1 is a (C 1-6 )alkyl or polyfluoro(C 1-6 )alkyl group; and R 2 is aryl, aryl-(C 1-10 )-alkyl, (C 4-7 )cycloalkyl or (C 4-7 )heterocycle wherein the heteroatom is an oxygen atom.
    一种制备化合物I的方法:其中,G为亚甲基,乙烯基,CONH,氨基或键;R为氢,苯基或(C1-4)烷基,可选地被苯基取代;Cy为苯基或由吡咯,咪唑,吡唑啉,吡咯烷,吡咯烷,咪唑啉,咪唑烷,吡唑烷,吡唑啉,吡啶,吡嗪,嘧啶,吡嗪,哌嗪,哌啶和三嗪组成的5-或6-成员杂环,Cy残基可选地被氧,硝基,羰基,氟,氯,溴或碘中的一个或多个取代基取代;R1为(C1-6)烷基或多氟(C1-6)烷基;R2为芳基,芳基-(C1-10)-烷基,(C4-7)环烷基或(C4-7)杂环,其中杂原子为氧原子。
  • PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS
    申请人:ZAMBON GROUP S.p.A.
    公开号:EP1042300A1
    公开(公告)日:2000-10-11
  • PHTHALAZINE DERIVATIVES USEFUL AS PHOSPHODIESTERASE 4 INHIBITORS
    申请人:ZAMBON GROUP S.p.A.
    公开号:EP1042300B1
    公开(公告)日:2004-02-11
  • US6589951B1
    申请人:——
    公开号:US6589951B1
    公开(公告)日:2003-07-08
查看更多